NCT01719523View on ClinicalTrials.gov

Open-Trial of EPI-743 for Adults With Tourette Syndrome

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Tourette Syndrome
Interventions
DRUG

EPI-743

Trial Locations (1)

06520

Yale Child Study Center, New Haven

Sponsors
All Listed Sponsors
collaborator

Rembrandt Foundation

UNKNOWN

collaborator

Edison Pharmaceuticals Inc

INDUSTRY

lead

Yale University

OTHER